Vimarsana
Biggest News Aggregation in the World

Page 21 - Lexaria Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Lexaria Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Lexaria Bioscience Today - Breaking & Trending Today

Lexaria's DehydraTECH-CBD Achieves Superior Human Blood Absorption Levels - Vimarsana News

Lexaria's DehydraTECH-CBD Achieves Superior Human Blood Absorption Levels

21.12.2022 - KELOWNA, BC / ACCESSWIRE / December 21, 2022 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the 'Company' or 'Lexaria'), a global innovator in drug delivery platforms is pleased to announce it has demonstrated superior cannabidiol ('CBD') ... Seite 1

Hill Street Beverage Company Inc.: Hill Street Announces Fully Subscribed $700,000 Private Placement of Units - Vimarsana News

Hill Street Beverage Company Inc.: Hill Street Announces Fully Subscribed $700,000 Private Placement of Units

Toronto, Ontario--(Newsfile Corp. - December 14, 2022) - Hill Street Beverage Company Inc. (TSXV: HILL) (OTC Pink: HSEEF) ("Hill Street" or the "Company"), a progressive bioscience implementation company

PCG Digital: Lexaria Bioscience Turns Focus to Dementia and Diabetes with New Studies - Vimarsana News

PCG Digital: Lexaria Bioscience Turns Focus to Dementia and Diabetes with New Studies

New York, New York--(Newsfile Corp. - November 21, 2022) - PCG Digital -- Lexaria Bioscience (NASDAQ: LEXX) is investigating the potential therapeutic utility of its proprietary DehydraTECHTM-CBD against

Hill Street Beverage Company Inc.: Hill Street Announces Warrant Extension and Repricing - Vimarsana News

Hill Street Beverage Company Inc.: Hill Street Announces Warrant Extension and Repricing

Toronto, Ontario--(Newsfile Corp. - November 18, 2022) - Hill Street Beverage Company Inc. (TSXV: HILL) ("Hill Street" or the "Company") announces today that it has extended the expiry date and reduced

Lexaria Bioscience Corp.: Lexaria Examining Potential Therapeutic Use of DehydraTECH-CBD in Dementia - Vimarsana News

Lexaria Bioscience Corp.: Lexaria Examining Potential Therapeutic Use of DehydraTECH-CBD in Dementia

KELOWNA, BC / ACCESSWIRE / November 10, 2022 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces that study program